| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K/A | 10-K | 10-K | 10-K | 10-K/A |
| Revenues: |
| Alliance BioEnergy Plus, Inc. | | | | | | | | 7.7 |
| Other | | | | | | | | -7.7 |
| Total revenues | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 7.5 | 5.3 | 0.0 |
| Revenue growth [+] | | | -100.0% | | -98.2% | 40.8% | | -100.0% |
| Alliance BioEnergy Plus, Inc. | | | | | | | | 248.7% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | -9.1 | 0.0 | 5.3 | -9.7 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.1 | 9.3 | 7.5 | 0.0 | 9.7 |
| Gross margin | | | | 100.0% | 6888.5% | 100.0% | 0.0% | |
| Selling, general and administrative [+] | 1.5 | 1.0 | 1.2 | 1.0 | 4.3 | 3.6 | 5.3 | 7.8 |
| General and administrative | 1.5 | 1.0 | 1.2 | 1.0 | 4.3 | 3.6 | 5.3 | 7.8 |
| Research and development | 2.4 | 1.1 | 0.8 | 0.8 | 0.7 | 0.7 | | |
| Equity in earnings | | | | | 0.2 | 0.2 | 0.2 | |
| Other operating expenses | 0.0 | 0.0 | | | 4.2 | 5.5 | | 7.8 |
| EBITDA [+] | -3.8 | -2.0 | -2.0 | -1.7 | 0.6 | -1.4 | -4.9 | -5.9 |
| EBITDA growth | 86.0% | 4.6% | 11.8% | | -143.3% | -70.9% | -16.7% | 167.7% |
| EBITDA margin | | | | -2908.8% | 460.9% | -19.1% | -92.2% | |
| Depreciation | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.0 |
| EBITA | -3.9 | -2.2 | -2.0 | -1.8 | 0.5 | -1.5 | -5.2 | -5.9 |
| EBITA margin | | | | -2961.1% | 397.2% | -20.0% | -96.6% | |
| Amortization of intangibles | | | | | 0.3 | 0.6 | | |
| EBIT [+] | -3.9 | -2.2 | -2.0 | -1.8 | 0.2 | -2.1 | -5.2 | -5.9 |
| EBIT growth | 81.1% | 9.1% | 12.1% | | -109.8% | -59.4% | -12.9% | 168.2% |
| EBIT margin | | | | -2961.1% | 152.4% | -27.8% | -96.6% | |
| Non-recurring items [+] | | | | | 4.9 | 2.1 | | 0.9 |
| Asset impairment | | | | | 4.1 | 3.2 | | 0.9 |
| Loss (gain) on sale of business | | | | | | -1.2 | | |
| Interest expense | 0.0 | 0.0 | 0.2 | | 0.9 | 1.3 | 0.2 | |
| Interest expense | 0.0 | 0.0 | 0.2 | | 0.9 | 1.3 | 0.2 | |
| Other income (expense), net [+] | 0.0 | 0.1 | | 2.8 | -4.6 | -3.4 | 0.5 | -3.1 |
| Gain (loss) on sale of assets | 0.0 | 0.0 | | | | | | |
| Gain (loss) on debt retirement | | | | -2.1 | -0.7 | 0.5 | 0.1 | |
| Other | | | | | -5.3 | -5.2 | -0.5 | |
| Pre-tax income | -4.0 | -2.1 | -2.2 | 1.0 | -10.3 | -8.8 | -4.8 | -9.9 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.5 | 0.3 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 5.2% | | 0.0% |
| Minority interest | | | | | | -0.5 | 0.3 | -0.1 |
| Earnings from continuing ops | -4.0 | -2.1 | -2.2 | 1.0 | -10.3 | -9.5 | -5.8 | -9.9 |
| Earnings from discontinued ops | | | | | 0.0 | 1.2 | 0.7 | -1.9 |
| Net income | -4.0 | -2.1 | -2.2 | 1.0 | -10.3 | -8.3 | -5.2 | -9.9 |
| Net margin | | | | 1675.2% | -7640.3% | -110.8% | -96.8% | |
| |
| Basic EPS [+] | ($0.01) | ($0.01) | ($0.01) | $0.01 | ($0.13) | ($0.16) | ($0.15) | ($0.27) |
| Growth | 79.0% | -16.4% | -256.8% | | -19.6% | 10.1% | -44.3% | 145.5% |
| Diluted EPS [+] | ($0.01) | ($0.01) | ($0.01) | $0.01 | ($0.13) | ($0.16) | ($0.15) | ($0.27) |
| Growth | 79.0% | -16.4% | -256.8% | | -19.6% | 10.1% | -44.3% | 145.5% |
| |
| Shares outstanding (basic) [+] | 278.8 | 269.6 | 229.9 | 166.1 | 77.6 | 57.6 | 39.0 | 37.0 |
| Growth | 3.4% | 17.3% | 38.4% | | 34.7% | 47.8% | 5.3% | 82.7% |
| Shares outstanding (diluted) [+] | 278.8 | 269.6 | 229.9 | 166.1 | 77.6 | 57.6 | 39.0 | 37.0 |
| Growth | 3.4% | 17.3% | 38.4% | | 34.7% | 47.8% | 5.3% | 82.7% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |